SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

75 hedge funds and large institutions have $641M invested in Sierra Oncology, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+29
Holders Change %
+63.04%
% of All Funds
1.19%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.13%
New
39
Increased
18
Reduced
13
Closed
10
Calls
$4.1M
Puts
$644K
Net Calls
+$3.46M
Net Calls Change
+$3.46M

Top Buyers

1
VC
Vivo Capital
California
$107M
2
PHS
PFM Health Sciences
California
$34.1M
3
O
OrbiMed
New York
$63M
4
Citadel Advisors
Citadel Advisors
Florida
$15M
5
Goldman Sachs
Goldman Sachs
New York
$14.1M

Top Sellers

1
FM
Frazier Management
Washington
$1.75M
2
DTC
Deep Track Capital
Connecticut
$0
3
IC
Ikarian Capital
Texas
$6.98M
4
NLVP
New Leaf Venture Partners
New York
$4.02M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
$32.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
VC
1
Vivo Capital
California
$107M +$45.3M +1,412,437 +74%
FLSM
2
Frazier Life Sciences Management
California
$75.1M +$75.1M +2,342,198 New
O
3
OrbiMed
New York
$63M +$15.6M +487,450 +33%
A
4
Abingworth
United Kingdom
$42.1M +$14M +437,356 +50%
RSCM
5
Rock Springs Capital Management
Maryland
$37.7M -$321K -10,007 -0.8%
PHS
6
PFM Health Sciences
California
$34.1M +$34.1M +1,062,888 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$32.1M -$7.39M -230,468 -19%
PBA
8
Paradigm Biocapital Advisors
New York
$24.7M +$9.5M +296,369 +62%
SI
9
Sofinnova Investments
California
$18.3M +$11.5M +360,016 +170%
Citadel Advisors
10
Citadel Advisors
Florida
$15M +$15M +467,809 New
BlackRock
11
BlackRock
New York
$14.4M +$13.6M +424,985 +1,813%
Goldman Sachs
12
Goldman Sachs
New York
$14.1M +$14.1M +441,005 New
LCM
13
Laurion Capital Management
New York
$13.6M +$13.6M +425,000 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$12M +$3.12M +97,391 +35%
GTC
15
Ghost Tree Capital
New York
$10.4M +$2.4M +75,000 +30%
TCM
16
Tang Capital Management
California
$9.62M +$9.62M +300,000 New
Two Sigma Investments
17
Two Sigma Investments
New York
$9.61M +$7.93M +247,437 +471%
Marshall Wace
18
Marshall Wace
United Kingdom
$9.13M +$9.13M +284,781 New
Two Sigma Advisers
19
Two Sigma Advisers
New York
$8.22M +$6.24M +194,800 +315%
IC
20
Ikarian Capital
Texas
$6.98M -$11.3M -351,114 -62%
KCM
21
Kynam Capital Management
New Jersey
$6.2M +$6.2M +193,280 New
JGC
22
J. Goldman & Co
New York
$5.34M +$5.34M +166,550 New
VA
23
VR Adviser
New York
$5.21M +$5.21M +162,479 New
PHP
24
Parkman Healthcare Partners
Connecticut
$4.87M +$4.87M +151,915 New
EI
25
EAM Investors
California
$4.38M +$4.38M +136,692 New
1
2 3 4